Hope Biosciences Receives Second FDA Clearance for a Phase II Clinical Trial for Protection Against COVID-19 Read more
Koselugo (selumetinib) approved in US for paediatric patients with neurofibromatosis type 1 plexiform neurofibromas Read more
Celltrion completes neutralization test on candidate mAbs for COVID-19 antiviral antibody treatment Read more
Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the Advancement of RNAi Therapeutics Read more
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development Read more